N. SOYER Et Al. , "Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data," IXth International Eurasian Hematology Oncology Congress , vol.73, pp.46, 2018
SOYER, N. Et Al. 2018. Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data. IXth International Eurasian Hematology Oncology Congress , 46.
SOYER, N., ALİ, R., TURGUT, M., HAZNEDAROĞLU, İ. C., yılmaz, f., AYDOĞDU, İ., ... PİR, A.(2018). Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data . IXth International Eurasian Hematology Oncology Congress (pp.46).
SOYER, NUR Et Al. "Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data," IXth International Eurasian Hematology Oncology Congress, 2018
SOYER, NUR Et Al. "Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data." IXth International Eurasian Hematology Oncology Congress , pp.46, 2018
SOYER, N. Et Al. (2018) . "Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data." IXth International Eurasian Hematology Oncology Congress , p.46.
@conferencepaper{conferencepaper, author={NUR SOYER Et Al. }, title={Retrospective and multicenter analysis of efficacy and safety ofruxolitinib in 176 Turkish patients with myelofibrosis: updated data}, congress name={IXth International Eurasian Hematology Oncology Congress}, city={}, country={}, year={2018}, pages={46} }